Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
16.2%
operating margin TTM
21.08%
revenue TTM
577.75 Million
revenue per share TTM
9.98$
valuation ratios | |
|---|---|
| pe ratio | 12.06 |
| peg ratio | -2.02 |
| price to book ratio | 1.93 |
| price to sales ratio | 1.96 |
| enterprise value multiple | 9.18 |
| price fair value | 1.93 |
profitability ratios | |
|---|---|
| gross profit margin | 76.55% |
| operating profit margin | 21.08% |
| pretax profit margin | 21.97% |
| net profit margin | 16.2% |
| return on assets | 11.45% |
| return on equity | 17.19% |
| return on capital employed | 17.97% |
liquidity ratios | |
|---|---|
| current ratio | 3.58 |
| quick ratio | 3.56 |
| cash ratio | 2.71 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 9.14 |
| operating cycle | 53.08 |
| days of payables outstanding | 49.51 |
| cash conversion cycle | 3.57 |
| receivables turnover | 8.31 |
| payables turnover | 7.37 |
| inventory turnover | 39.93 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.16 |
| debt equity ratio | 0.23 |
| long term debt to capitalization | 0.13 |
| total debt to capitalization | 0.18 |
| interest coverage | 13.49 |
| cash flow to debt ratio | 1.66 |
cash flow ratios | |
|---|---|
| free cash flow per share | 5.91 |
| cash per share | 11.08 |
| operating cash flow per share | 5.91 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 1.66 |
| short term coverage ratios | 5.41 |
| capital expenditure coverage ratio | 1,878.97 |
Frequently Asked Questions
When was the last time Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) reported earnings?
Harmony Biosciences Holdings, Inc. (HRMY) published its most recent earnings results on 07-05-2026.
What is Harmony Biosciences Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)'s trailing twelve months ROE is 17.19%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Harmony Biosciences Holdings, Inc. (HRMY) currently has a ROA of 11.45%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HRMY's net profit margin stand at?
HRMY reported a profit margin of 16.2% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HRMY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.58 in the most recent quarter. The quick ratio stood at 3.56, with a Debt/Eq ratio of 0.23.